Quick Order Cart

Cat. No. ARG27668

KDELR3 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

KDELR3 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of near-haploid HAP1 cells, targeting KDELR3, the receptor for KDEL-mediated Golgi-to-ER retrieval. Regulated by XBP1 and ATF6, KDELR3 interacts with BiP/GRP78 and COPI components, and its loss impairs ER proteostasis, activating UPR and ERAD pathways. This model is valuable for studies on protein trafficking, ER stress, and cancer cell biology. Applications include Western blotting for KDEL clients, immunofluorescence with ER/Golgi markers, RT-qPCR for UPR targets, and viability assays under ER stress. Researchers can use this model to explore drug sensitivity and metastasis mechanisms. For inquiries, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KDELR3

    Gene Identifier

    NCBI Gene ID 11015

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

KDELR3 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the near-haploid HAP1 cell line, designed for loss-of-function studies of the KDELR3 gene. This gene-edited pool provides a genetically heterogeneous model with disrupted KDELR3 expression, enabling investigation of ER protein retrieval and Golgi-to-ER retrograde transport. The polyclonal format preserves population-level genetic diversity, suitable for pooled screens and assays where clonal artifacts are undesirable.

HAP1 is a near-haploid human cell line originally derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype facilitates genetic manipulation and phenotype interpretation, making it a preferred system for knockout studies and haploid genetic screens. The HAP1 background retains key features of leukemic cells, providing a relevant context for studying protein trafficking pathways implicated in cancer biology and drug responsiveness.

KDELR3 encodes a receptor that recognizes the C-terminal KDEL motif on ER-resident proteins that have escaped to the cis-Golgi, mediating their retrograde transport back to the ER via COPI-coated vesicles. This retrieval process is essential for maintaining ER proteostasis. KDELR3 functions downstream of ER stress sensors such as XBP1 and ATF6, which transcriptionally upregulate its expression during the unfolded protein response (UPR). It directly interacts with KDEL-containing client proteins, including the chaperone BiP/GRP78 and protein disulfide isomerase (PDI), as well as with COPI coat components like ??-COP and the small GTPase ARF1. KDELR3 cycles between the ER and Golgi through the ERGIC, cooperating with factors such as ERGIC-53, Sar1, and Rab6. Disruption of KDELR3 impairs retrieval of these clients, leading to ER stress and activation of downstream UPR targets, including Calreticulin and ERp57.

In the HAP1 background, KDELR3 knockout provides a powerful tool to dissect COPII-mediated anterograde and COPI-dependent retrograde transport pathways without the complexity of diploid genomes. The near-haploid nature ensures that gene disruption is effectively unmasked, facilitating clear genotype-phenotype correlations. This model is particularly valuable for studying ER stress, ER-associated degradation (ERAD), and the UPR, as well as their roles in cancer metastasis and drug resistance. Given the HAP1 cell’s origins from chronic myeloid leukemia, the knockout can be applied to investigate how ER proteostasis influences leukemic cell survival, proliferation, and sensitivity to chemotherapeutics.

Typical applications include monitoring ER stress responses via Western blotting for KDEL-bearing proteins, immunofluorescence co-localization with ER and Golgi markers, RT-qPCR for UPR target genes such as BiP and PDI, flow cytometry for ER stress sensors, and cell viability assays under ER stress. The polyclonal cell population is also suited for functional genomic screens and high-content imaging studies assessing protein trafficking dynamics. For additional information or technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)